Regulatory Compliance

The Accumulator Adjustment Ruling of 2023 – What’s Next for Brands

On May 17, 2022, the U.S. District Court for DC ruled against the “accumulator adjustment rule.” What impact will this have on pharma?

Learn more →

The 340B Program: How Manufacturers, Plan Sponsors, and Brokers Should React

340B is increasingly a part of the pharmacy conversation. How should stakeholders react to the program?

Learn more →

Industry Update: The Impact of State Legislation on Copay Accumulator Programs

Several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?

Learn more →